Impaired TLR3/IFN-β signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: Relevance to the severity of liver damage

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 630-635

  Li, Ning ^a   Li, Qian ^a   Qian, Zhiping ^b   Zhang, Yujie ^a   Chen, Mingquan ^a   Shi, Guangfeng ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Acute on chronic liver failure; Dendritic cell; Hepatitis B; Interferon ; Toll like receptor 3

Indexed keywords

B7 ANTIGEN; BETA INTERFERON; BILIRUBIN; BIOLOGICAL MARKER; CD4 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; MESSENGER RNA; PROTHROMBIN; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; LIVER FAILURE; LIVER FUNCTION TEST; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DENDRITIC CELLS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-BETA; LIVER FAILURE; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MONOCYTES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 3; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 70449705835     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.018     Document Type: Article

References (29)

1. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5 (2005) 215-229
2. Sen S., Williams R., and Jalan R. The pathophysiological basis of acute-on-chronic liver failure. Liver 22 (2002) 5-13
3. Zou Z.S., Li B.S., Xu D.P., Zhang Z., Zhao J.M., Zhou G.D., Sun Y.L., Huang L., Fu J.L., Yang Y.P., Jin L., Zhang W., Zhao J., Sun Y., Xin S.J., and Wang F.S. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection. J. Clin. Gastroenterol. 43 (2009) 182-190
4. Xu D.P., Fu J.L., Jin L., Zhang H., Zhou C.B., Zou Z.S., Zhao J.M., Zhang B., Shi M., Ding X.L., Tang Z.R., Fu Y.X., and Wang F.S. Circulating and liver resident CD4(+)CD25(+) regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B-1. J. Immunol. 177 (2006) 739-747
5. Duan X.Z., Wang M., Li H.W., Zhuang H., Xu D., and Wang F.S. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J. Clin. Immunol. 24 (2004) 637-646
6. van der Molen R.G., Sprengers D., Binda R.S., de Jong E.C., Niesters H.G.M., Kusters J.G., Kwekkeboom J., and Janssen H.L.A. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40 (2004) 738-746
7. Zhang Z., Zou Z.S., Fu J.L., Cai L., Jin L., Liu Y.J., and Wang F.S. Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure. J. Hepatol. 49 (2008) 396-406
8. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9 (1991) 271-296
9. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
10. Chang S., Dolganiuc A., and Szabo G. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J. Leukoc. Biol. 82 (2007) 479-487
11. Isogawa M., Robek M.D., Furuichi Y., and Chisari F.V. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J. Virol. 79 (2005) 7269-7272
12. Naka K., Dansako H., Kobayashi N., Ikeda M., and Kato N. Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via toll-like receptor 3 signaling pathway without replicating viral genomes. Virology 346 (2006) 348-362
13. Wu J., Lu M.J., Meng Z.J., Trippler M., Broering R., Szczeponek A., Krux F., Dittmer U., Roggendorf M., Gerken G., and Schlaak J.F. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46 (2007) 1769-1778
14. Wu J., Meng Z.J., Jiang M., Pei R.J., Trippler M., Broering R., Bucchi A., Sowa J.P., Dittmer U., Yang D.L., Roggendorf M., Gerken G., Lu M.J., and Schlaak J.F. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49 (2009) 1132-1140
15. Xu N., Yao H.P., Sun Z., and Chen Z. Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis B and related hepatocellular carcinoma. Acta Pharmacol. Sin. 29 (2008) 239-244
16. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat. Immunol. 7 (2006) 131-137
17. Schroder M., and Bowie A.G. TLR3 in antiviral immunity: key player or bystander?. Trends Immunol. 26 (2005) 462-468
18. Shi G.F., Chen M.Q., and Li Q. Study on the expression of toll-like receptor 3 (TLR3) on dendritic cells derived from peripheral blood monocyte of chronic hepatitis B patients. J. Hepatol. 46 (2007) S159
19. Sarin S.K., Kumar A., Almeida J.A., Chawla Y.K., Fan S.T., Garg H., de Silva H.J., Hamid S.S., Jalan R., Komolmit P., Lau G.K., Liu Q., Madan K., Mohamed R., Ning Q., Rahman S., Rastogi A., Riordan S.M., Sakhuja P., Samuel D., Shah S., Sharma B.C., Sharma P., Takikawa Y., Thapa B.R., Wai C.T., and Yuen M.F. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol. Int. 3 (2009) 269-282
20. Jiang X.X., Zhang Y., Liu B., Zhang S.X., Wu Y., Yu X.D., and Mao N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105 (2005) 4120-4126
21. Verdijk R.M., Mutis T., Esendam B., Kamp J., Melief C.J.M., Brand A., and Goulmy E. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J. Immunol. 163 (1999) 57-61
22. Maire M., Parent R., Morand A.L., Alotte C., Trepo C., Durantel D., and Petit M.A. Characterization of the double-stranded RNA responses in human liver progenitor cells. Biochem. Biophys. Res. Commun. 368 (2008) 556-562
23. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., and Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643
24. Ke W.M., Ye Y.N., and Huang S. Discriminant function for prognostic indexes and probability of death in chronic severe hepatitis B. J. Gastroenterol. 38 (2003) 861-864
25. Kabelitz D., and Medzhitov R. Innate immunity-cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Curr. Opin. Immunol. 19 (2007) 1-3
26. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5 (2004) 987-995
27. Visvanathan K., Skinner N.A., Thompson A.J.V., Riordan S.M., Sozzi V., Edwards R., Rodgers S., Kurtovic J., Chang J., Lewin S., Desmond P., and Locarnini S. Regulation of toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45 (2007) 102-110
28. Chang J.J., Thompson A.J., Visvanathan K., Kent S.J., Cameron P.U., Wightman F., Desmond P., Locarnini S.A., and Lewin S.R. The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection. Hepatology 46 (2007) 1332-1340
29. Wilson J.R., de Sessions P.F., Leon M.A., and Scholle F. West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J. Virol. 82 (2008) 8262-8271